Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-19 4:38 pm Purchase | 2024-01-11 | 13G | DYNE THERAPEUTICS INC DYN | Deep Track Capital, LP | 4,500,000 5.550% | 2,500,000 (+125.00%) | Filing History |
| 2024-01-19 09:08 am Sale | 2023-12-31 | 13G | DYNE THERAPEUTICS INC DYN | Deep Track Capital, LP | 2,000,000 3.260% | -684,200 (-25.49%) | Filing History |
| 2023-02-14 4:29 pm Unchanged | 2022-12-31 | 13G | DYNE THERAPEUTICS INC DYN | Atlas Venture Fund XI, L.P. | 7,326,117 14.100% | 0 (Unchanged) | Filing History |
| 2023-02-14 3:53 pm Sale | 2022-12-31 | 13G | DYNE THERAPEUTICS INC DYN | Logos Global Management LP | 2,150,000 4.100% | -804,392 (-27.23%) | Filing History |
| 2023-02-14 08:32 am Sale | 2022-12-31 | 13G | DYNE THERAPEUTICS INC DYN | Deep Track Capital, LP | 2,684,200 5.150% | -132,750 (-4.71%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | DYNE THERAPEUTICS INC DYN | Citadel Advisors LLC | 2,981,324 5.700% | 116,524 (+4.07%) | Filing History |
| 2023-02-10 4:31 pm Sale | 2022-08-15 | 13D | DYNE THERAPEUTICS INC DYN | Vida Ventures II LLC | 2,220,034 4.300% | -740,012 (-25.00%) | Filing History |
| 2023-02-09 4:04 pm Purchase | 2022-12-31 | 13G | DYNE THERAPEUTICS INC DYN | MPM BIOVENTURES 2018, L.P. | 4,970,899 9.500% | 19,596 (+0.40%) | Filing History |
| 2023-02-09 11:01 am Sale | 2023-01-31 | 13G | DYNE THERAPEUTICS INC DYN | BlackRock Inc. BLK | 2,593,524 4.900% | -25,094 (-0.96%) | Filing History |
| 2023-02-08 2:57 pm Purchase | 2022-12-31 | 13G | DYNE THERAPEUTICS INC DYN | BlackRock Inc. BLK | 2,618,618 5.000% | 2,618,618 (New Position) | Filing History |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | DYNE THERAPEUTICS INC DYN | RA Capital Management, L.P. | 0 0.000% | -2,805,045 (Position Closed) | Filing History |
| 2022-02-14 4:11 pm Unchanged | 2021-12-31 | 13G | DYNE THERAPEUTICS INC DYN | RA Capital Management, L.P. | 2,805,045 5.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:10 pm Sale | 2021-12-31 | 13G | DYNE THERAPEUTICS INC DYN | Logos Global Management LP | 2,954,392 5.700% | -940,000 (-24.14%) | Filing History |
| 2022-02-14 06:12 am Sale | 2021-12-31 | 13G | DYNE THERAPEUTICS INC DYN | Citadel Advisors LLC | 2,864,800 5.600% | -299,601 (-9.47%) | Filing History |
| 2022-02-11 5:04 pm Sale | 2021-12-31 | 13G | DYNE THERAPEUTICS INC DYN | Atlas Venture Fund XI, L.P. | 7,326,117 14.200% | -814,013 (-10.00%) | Filing History |
| 2022-02-04 09:17 am Sale | 2021-12-31 | 13G | DYNE THERAPEUTICS INC DYN | Wellington Management Group LLP | 1,763,053 3.420% | -1,141,669 (-39.30%) | Filing History |
| 2022-01-20 4:27 pm Purchase | 2022-01-18 | 13G | DYNE THERAPEUTICS INC DYN | Deep Track Capital, LP | 2,816,950 5.470% | 2,816,950 (New Position) | Filing History |
| 2021-08-16 2:37 pm Purchase | 2021-08-05 | 13G | DYNE THERAPEUTICS INC DYN | Logos Global Management LP | 3,894,392 7.600% | 3,894,392 (New Position) | Filing History |